BioPredictive · FibroMax
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | Request PDF
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?
Biomedicines | Free Full-Text | Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
Clinical case: NAFLD
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise | Nature Reviews Gastroenterology & Hepatology
Nonalcoholic Fatty Liver Disease: Diagnosis and Management | AAFP
BioPredictive · FibroTest-ActiTest
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. - Abstract - Europe PMC
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers - ScienceDirect
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
